Verona Pharma Plc Adr (VRNA)

Nov 07, 2025

Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) Receives Average Rating of “Hold” from Brokerages - Defense World

Nov 07, 2025

Oct 19, 2025

US Bancorp DE Has $748,000 Holdings in Verona Pharma PLC American Depositary Share $VRNA - Defense World

Oct 19, 2025

Oct 08, 2025

VRNA: Cantor Fitzgerald Maintains Overweight Rating with $100 PT - GuruFocus

Oct 08, 2025

Oct 08, 2025

Verona Pharma plc (VRNA)’s Shareholders Authorizes the $10 Billion Acquisition of Verona Pharma plc (VRNA); Nasdaq Trading to Suspend - Yahoo Finance

Oct 08, 2025

Oct 07, 2025

Merck completes acquisition of Verona Pharma; VRNA shares delisted from Nasdaq - Investing.com

Oct 07, 2025

Oct 07, 2025

BioSpace Announces Inaugural 40 Under 40 Winners (2025-10-07) - Seeking Alpha

Oct 07, 2025

Oct 07, 2025

Verona Pharma (VRNA): A Fresh Look at Current Valuation and Market Expectations - Sahm

Oct 07, 2025

Oct 07, 2025

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales - Sahm

Oct 07, 2025

Oct 07, 2025

Verona Pharma stock hits all-time high at 106.91 USD By Investing.com - Investing.com Canada

Oct 07, 2025

Oct 06, 2025

Court approves MSD’s $10 billion acquisition of Verona Pharma - Investing.com

Oct 06, 2025

Oct 06, 2025

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales - Benzinga

Oct 06, 2025

Oct 06, 2025

Verona Pharma stock hits all-time high at 106.91 USD - Investing.com

Oct 06, 2025

Oct 03, 2025

Is There Still Opportunity in Verona Pharma After Ohtuvayre Approval and 246% Price Surge? - Sahm

Oct 03, 2025

Sep 30, 2025

VRNA Quantitative Stock Analysis - Nasdaq

Sep 30, 2025

Sep 26, 2025

Verona Pharma stock reaches all-time high at 106.75 USD By Investing.com - Investing.com Nigeria

Sep 26, 2025

Sep 25, 2025

Verona Pharma stock reaches all-time high at 106.75 USD - Investing.com India

Sep 25, 2025

Sep 24, 2025

Verona Pharma shareholders approve $10 billion Merck acquisition - Investing.com

Sep 24, 2025

Sep 17, 2025

AstraZeneca Asthma Drug Fails COPD Study for a Second Time - Bloomberg.com

Sep 17, 2025

Sep 15, 2025

Verona Pharma stock hits all-time high at 106.45 USD - Investing.com India

Sep 15, 2025

Sep 15, 2025

Verona Pharma stock hits all-time high at 106.45 USD By Investing.com - Investing.com Canada

Sep 15, 2025

Sep 10, 2025

Verona Pharma Extends Severance Benefits Amid Merck Deal - The Globe and Mail

Sep 10, 2025

Sep 09, 2025

Invesco Ltd. Makes New Investment in Verona Pharma PLC American Depositary Share $VRNA - Defense World

Sep 09, 2025

Sep 05, 2025

Verona Pharma stock hits all-time high at 106.19 USD By Investing.com - Investing.com Australia

Sep 05, 2025

Sep 04, 2025

Verona Pharma stock hits all-time high at 106.19 USD - Investing.com

Sep 04, 2025

Sep 02, 2025

Merck Taps US Investment-Grade Bond Market for Verona Purchase - Bloomberg.com

Sep 02, 2025

Aug 29, 2025

Verona Pharma stock hits all-time high at 105.86 USD By Investing.com - Investing.com Australia

Aug 29, 2025

Aug 28, 2025

Verona Pharma stock hits all-time high at 105.86 USD - Investing.com

Aug 28, 2025

Aug 19, 2025

TRAILBLAZERS TAKE THE STAGE: PM360 TO CROWN LIFE SCIENCES' BRIGHTEST, SEPTEMBER 30 - Seeking Alpha

Aug 19, 2025

Aug 18, 2025

Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck - MSN

Aug 18, 2025

Aug 18, 2025

Verona Pharma : Notice of Meetings and Proxy Statement in connection with proposed acquisition of Verona Pharma - MarketScreener

Aug 18, 2025

Aug 18, 2025

Verona Pharma stock reaches all-time high at 105.54 USD By Investing.com - Investing.com Nigeria

Aug 18, 2025

Aug 18, 2025

Verona Pharma stock reaches all-time high at 105.54 USD - Investing.com

Aug 18, 2025

Aug 17, 2025

Merck to Acquire Verona Pharma in $10 Billion Deal to Expand Respiratory Drug Portfolio - MSN

Aug 17, 2025

Aug 08, 2025

Verona Pharma ADR earnings beat by $0.11, revenue topped estimates - Investing.com Nigeria

Aug 08, 2025

Aug 05, 2025

Verona Pharma CFO Hahn sells $2.75 million in shares By Investing.com - Investing.com India

Aug 05, 2025

Aug 05, 2025

Verona Pharma (VRNA) director Ackermann sells $24k in shares - Investing.com

Aug 05, 2025

Aug 05, 2025

Verona Pharma CFO Hahn sells $2.75 million in shares - Investing.com

Aug 05, 2025

Aug 05, 2025

Verona Pharma director Cunningham sells shares for $142,057 By Investing.com - Investing.com South Africa

Aug 05, 2025

Aug 05, 2025

Verona Pharma (VRNA) director Deschamps sells $124,391 in shares - Investing.com India

Aug 05, 2025

Aug 05, 2025

Verona Pharma director Cunningham sells shares for $142,057 - Investing.com India

Aug 05, 2025

Aug 05, 2025

VERONA PHARMA PLCADR: Quantitative Momentum Investor Model Ratings - AInvest

Aug 05, 2025

Jul 31, 2025

Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $135,000 Today - The Globe and Mail

Jul 31, 2025

Jul 25, 2025

Verona Pharma stock hits all-time high at 105.31 USD By Investing.com - Investing.com Nigeria

Jul 25, 2025

Jul 25, 2025

Verona Pharma stock hits all-time high at 105.31 USD - Investing.com

Jul 25, 2025

Jul 23, 2025

Verona Pharma Plc ADR’s Shares Reel: 69.24% Quarterly Revenue Decline Amid 8.93B Market Cap - investchronicle.com

Jul 23, 2025

Jul 19, 2025

Verona Pharma stock reaches all-time high at 105.0 USD By Investing.com - Investing.com Australia

Jul 19, 2025